Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
09/02/1998 | EP0533898B1 Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions |
09/02/1998 | EP0482213B1 Antineoplastic agent |
09/02/1998 | EP0429628B1 Dna sequences, vectors, and fusion polypeptides to increase secretion of desired polypeptides from filamentous fungi |
09/02/1998 | CN1192246A Cell line producing analgesic compounds for treating pain |
09/02/1998 | CN1192245A Use of gram-positive bacteria to express recombinant proteins |
09/02/1998 | CN1192241A Streptococcal heat shock proteins members of the HSP70 family |
09/02/1998 | CN1192240A Recombinant mistletoe lectin (rML) |
09/02/1998 | CN1192237A 人MP52 Arg蛋白 People MP52 Arg protein |
09/02/1998 | CN1192234A Replacement therapy for dental caries |
09/02/1998 | CN1192220A Novel antiproliferative protein from bacillus thuringiensis var. Thuringiensis |
09/02/1998 | CN1192219A Reversible cysteine protease inhibitors |
09/02/1998 | CN1192158A Method of treatment for asthma |
09/02/1998 | CN1192156A Treatment of T cell mediated autoimmune disorders |
09/02/1998 | CN1192155A Hemodilution facilitated by monitoring oxygenation status |
09/02/1998 | CN1192153A aPL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies |
09/02/1998 | CN1192152A Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides |
09/02/1998 | CN1191898A Self-enhancing, pharmacologically controllable expression systems |
09/01/1998 | USRE35886 Endothelin-converting enzyme inhibitor |
09/01/1998 | US5801235 Oligonucleotides with anti-cytomegalovirus activity |
09/01/1998 | US5801234 Polynucleotide encoding saliva binding protein |
09/01/1998 | US5801227 Antibodies to CD40 |
09/01/1998 | US5801226 Oral care compositions |
09/01/1998 | US5801222 Isolation and structure of the human cancer cell growth inhibitory cyclic octapeptides phakellistatin 10 and 11 |
09/01/1998 | US5801203 Nitroglycerine patch |
09/01/1998 | US5801200 Methods and materials for the diagnosis and treatment of conditions such as stroke |
09/01/1998 | US5801162 Containing tissue plasminogen activator |
09/01/1998 | US5801159 Method and composition for inhibiting cellular irreversible changes due to stress |
09/01/1998 | US5801157 Plasmid contained in oil in water or water in oil emulsion and comprising protein, glycoprotein or peptide |
09/01/1998 | US5801156 Macular degeneration |
09/01/1998 | US5801154 Antisense oligonucleotide modulation of multidrug resistance-associated protein |
09/01/1998 | US5801149 Peptids for inhibition of proteins |
09/01/1998 | US5801148 Serine protease inhibitors-proline analogs |
09/01/1998 | US5801147 Polypeptides and use thereof |
09/01/1998 | US5801146 Compound and method for inhibiting angiogenesis |
09/01/1998 | US5801144 Use of a compound for the manufacture of a medicament for the treatment of HIV infection |
09/01/1998 | US5801143 Cyclic depsipeptides useful for treatment of hyperlipemia |
09/01/1998 | US5801142 Human mts-1 protein |
09/01/1998 | US5801141 Drug delivery |
09/01/1998 | US5801044 Nucleic acid encoding an antibody that inhibits cell adhesion protein-carbohydrate interactions |
09/01/1998 | US5801042 Dna and nucleic acids for herpesvirus glycoprotein h, plasmids and genomes |
09/01/1998 | US5801040 Nucleic acid coding for the human testicular angiotensin converting enzyme (ACE ) and its uses, especially for the in vitro screening for this enzyme in the organism |
09/01/1998 | US5801037 Expression of signal-peptide-free staphylokinases |
09/01/1998 | US5801033 Gels for encapsulation of biological materials |
09/01/1998 | US5801022 Method of producing a product with crosslinked crystals of thermolysin |
09/01/1998 | US5801020 Antibiotic producing microbe |
09/01/1998 | US5801019 DNA encoding fused alpha-beta globin pseuodimer and production of pseudotetrameric hemoglobin |
09/01/1998 | US5801017 Production of recombinant factor Xa inhibitor of leech Hirudo medicinalis |
09/01/1998 | US5801014 Growth differentiation factor-5 |
09/01/1998 | US5801012 Methods and compositions for generating angiostatin |
09/01/1998 | US5801005 Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated |
09/01/1998 | US5801001 Method of detecting cancer |
09/01/1998 | US5801000 Isolation from a sample a receptor for binding a polypeptide then isolation |
09/01/1998 | US5800998 Assays for diagnosing type II diabetes in a subject |
09/01/1998 | US5800991 Nucleotide or nucleoside photoaffinity compound modified antibodies, methods for their manufacture and use thereof as diagnostics and therapeutics |
09/01/1998 | US5800980 Detection of MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, by nucleic acid hybridization |
09/01/1998 | US5800838 Conbating sexually transmitted diseases; antiseptics |
09/01/1998 | US5800828 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products |
09/01/1998 | US5800820 Antitumor agents for lungs |
09/01/1998 | US5800815 Antibodies to P-selectin and their uses |
09/01/1998 | US5800814 Method for inhibition of breast tumor growth |
09/01/1998 | US5800812 Methods of use of mononuclear phagocytes to promote axonal regeneration |
09/01/1998 | US5800811 Artificial skin prepared from coclagen matrix containing transforming growth factor-β having a collagen binding site |
09/01/1998 | US5800810 Human IL-2 as a vaccine adjuvant |
09/01/1998 | US5800808 Copolymer-1 improvements in compositions of copolymers |
09/01/1998 | US5800385 Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis |
09/01/1998 | CA2086874E Methods for administration of taxol |
09/01/1998 | CA2069501C Monoclonal antibody which distinguishes helper inducer and suppressor inducer cd4+ lymphocytes |
09/01/1998 | CA1340018C Monoclonal antibodies reactive with cachetin |
08/28/1998 | CA2230497A1 Novel lica |
08/28/1998 | CA2230490A1 Novel licc |
08/28/1998 | CA2230478A1 Novel licd2 |
08/28/1998 | CA2230473A1 Novel licd1 |
08/28/1998 | CA2230467A1 Novel licb |
08/27/1998 | WO1998037415A1 ULCERATIVE COLITIS pANCA SECRETORY VESICLE ANTIGEN AND METHODS OF USING SAME |
08/27/1998 | WO1998037240A1 Anti-sense oligonucleotide pharmacological agents |
08/27/1998 | WO1998037239A1 Diagnosis and treatment of chronic fatigue syndrome from variations in arginine-vasopressin receptor 2 |
08/27/1998 | WO1998037228A1 IλB KINASE, SUBUNITS THEREOF, AND METHODS OF USING SAME |
08/27/1998 | WO1998037224A1 Transgenically produced non-secreted proteins |
08/27/1998 | WO1998037217A1 A soluble vaccinia virus protein that binds chemokines |
08/27/1998 | WO1998037210A1 Immunological detection of prions |
08/27/1998 | WO1998037207A1 Antitumor genetic constructs |
08/27/1998 | WO1998037200A2 Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies |
08/27/1998 | WO1998037199A1 Novel human mlf3 protein |
08/27/1998 | WO1998037198A1 Human sodium-dependent phosphate cotransporter |
08/27/1998 | WO1998037197A1 Novel microtubule-associated protein |
08/27/1998 | WO1998037196A1 PARG, A GTPase ACTIVATING PROTEIN WHICH INTERACTS WITH PTPL1 |
08/27/1998 | WO1998037195A1 Morphogenic proteins |
08/27/1998 | WO1998037194A1 Ell2, a member of an ell family of rna polymerase ii elongation factors |
08/27/1998 | WO1998037192A1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes |
08/27/1998 | WO1998037191A1 Human circulating hnlp (human neutrophil lymphocyte peptide) |
08/27/1998 | WO1998037190A1 Method for induction of apoptotic cell death in malignant cells, through reduction of the rb to apoptosis inducing proteins ratio |
08/27/1998 | WO1998037188A1 OLIGONUCLEOTIDES SPECIFIC FOR THE marORAB OPERON |
08/27/1998 | WO1998037182A1 Oviductal catalase binding to the membranes of spermatozoa and uses thereof |
08/27/1998 | WO1998037180A2 Hcv fusion protease and polynucleotide encoding same |
08/27/1998 | WO1998037178A1 Immunomodulatory polypeptides derived from the invariant chain of mhc class ii |
08/27/1998 | WO1998037100A2 Therapeutic use of the smr1 protein and active derivatives thereof |
08/27/1998 | WO1998037099A1 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics |
08/27/1998 | WO1998037098A1 Eukaryotic cells expressing at their surface at least an hla-g isoform and their applications |
08/27/1998 | WO1998037097A1 Msh-receptor subtype selective cyclic peptides |
08/27/1998 | WO1998037094A2 Secreted proteins and polynucleotides encoding them |